Zusammenfassung
Die diabetische Retinopathie (DR) ist die Hauptursache für Erblindung in den Industrienationen. Nach 15- bis 20-jähriger Erkrankungsdauer sind ca. 95 % der Patienten hiervon betroffen. Neben den hohen sozioökonomischen Kosten ergeben sich verschiedene wichtige Aspekte im beruflichen Kontext. Diese Arbeit gibt eine Übersicht über den aktuellen Stand der DR hinsichtlich Epidemiologie, Pathologie, Diagnostik und Therapie sowie unter besonderer Berücksichtigung arbeitsmedizinischer Aspekte.
Abstract
Diabetic retinopathy (DR) is the main cause of blindness in industrialized countries. Approximately 95 % of all patients with diabetes will develop some degree of DR after 15–20 years duration of the disease. Besides the enormous socioeconomic costs, there are various aspects of major occupational importance. The article gives a review of the current knowledge about epidemiology, pathology, diagnostics and therapy on DR with a particular emphasis on occupational medical aspects.
Literatur
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487
Aiello LP, Sun W, Das A et al (2015) Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med 372:1722–1733
Boehme MW, Buechele G, Frankenhauser-Mannuss J et al (2015) Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany – a retrospective cohort and case control study in claims data of a large statutory health insurance. BMC Public Health 15:855
De Clerck EE, Schouten JS, Berendschot TT et al (2015) New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic review. Lancet 3:653–663
Fong DS, Aiello LP, Ferris FL 3rd et al (2004) Diabetic retinopathy. Diabetes Care 27:2540–2553
Hammes HP, Lemmen KD, Jochmann C et al (2006) [Diabetic retinopathy and maculopathy]. Dtsch Med Wochenschr 131:1173–1175. (1946)
Heller T, Blum M, Spraul M et al (2014) [Diabetic co-morbidities: prevalences in Germany]. Dtsch Med Wochenschr 139:786–791. (1946)
Hutchinson A, Mcintosh A, Peters J et al (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy–a systematic review. Diabet Med 17:495–506
Koya D, King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859–866
Lang GE (2007) Pharmacological treatment of diabetic retinopathy. Ophthalmologica 221:112–117
Lippmann-Grob B, Bierwirth RA, Kron P et al (2004) [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study]. Dtsch Med Wochenschr 129:75–81. (1946)
Mehrtens G, Valentin H, Schönberger A (2003) Arbeitsunfall und Berufskrankheit. Erich Schmidt Verlag GmbH & Co, Berlin, S 1373
Robison WG Jr, Nagata M, Laver N et al (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 30:2285–2292
Singh R, Ramasamy K, Abraham C et al (2008) Diabetic retinopathy: an update. Indian J Ophthalmol 56:178–188
Strom C, Sander B, Klemp K et al (2005) Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema. Invest Ophthalmol Vis Sci 46:3855–3858
Xia P, Aiello LP, Ishii H et al (1996) Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018–2026
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
N. Schöffel, N. Wahrlich, J. Bauer, M.H.K. Bendels und D.A. Groneberg geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Diese Arbeit ist Teil eines Promotionsverfahrens von N. Wahrlich.
Rights and permissions
About this article
Cite this article
Schöffel, N., Wahrlich, N., Bauer, J. et al. Diabetische Retinopathie. Zbl Arbeitsmed 66, 101–104 (2016). https://doi.org/10.1007/s40664-015-0082-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40664-015-0082-4